Ignalis-M IR 50/500 Tablet
By Ignalis-M
Rx
10 Tablet in a Strip

Composition
Sitagliptin(50mg) + Metformin(500mg)

Manufacturer - Intas Pharmaceuticals Ltd
Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.

Expires on or after
April, 2026
About Ignalis-M IR 50/500 Tablet
Ignalis-M IR 50/500 Tablet is a combination medication designed to manage high blood sugar levels in individuals diagnosed with type 2 diabetes mellitus, a chronic condition that can lead to serious complications if not properly controlled. By combining two active ingredients, Sitagliptin and Metformin, this tablet helps regulate blood sugar levels to prevent conditions such as kidney damage, vision loss, heart attacks, and strokes.
Sitagliptin, a DPP-4 inhibitor, works by increasing natural substances that lower high blood sugar levels. On the other hand, Metformin, a biguanide, controls glucose production in the liver, delays glucose absorption from the intestines, and enhances the body's sensitivity to insulin. By addressing insulin resistance and reducing excessive sugar levels in the blood, Ignalis-M IR 50/500 Tablet effectively manages diabetes.
It is recommended to take Ignalis-M IR 50/500 Tablet with meals to minimize the risk of stomach upset. Consistency is key when using this medication, so it is crucial to take it at the same time each day as prescribed by your doctor for optimal results. Dosage adjustments may be necessary based on your individual condition and blood sugar levels.
While Ignalis-M IR 50/500 Tablet can offer important benefits in managing diabetes, it is essential to be aware of potential side effects. Common side effects may include diarrhea, nausea, vomiting, headache, and sore throat. Monitoring for low blood sugar levels (hypoglycemia) is important, especially if you are taking other diabetes medications concurrently.
Before starting Ignalis-M IR 50/500 Tablet, inform your doctor about any existing kidney, liver, or heart issues, as well as conditions like pancreas problems or excessive alcohol consumption. Pregnant or breastfeeding individuals should consult their healthcare provider before using this medication. It is also important to disclose all other medications you are taking to ensure compatibility and safety.
Regular monitoring of kidney function and blood sugar levels during treatment is essential to assess the medication's effectiveness and detect any potential issues early on. Lifestyle modifications, including following a recommended diet, engaging in regular exercise, and avoiding excessive alcohol intake, are also crucial aspects of managing diabetes effectively while using Ignalis-M IR 50/500 Tablet.
Benefits
Ignalis-M IR 50/500 Tablet offers numerous benefits in the treatment of Type 2 diabetes mellitus. This medication contains a combination of two powerful medicines that work synergistically to effectively lower your blood glucose levels. By keeping your blood glucose under control, Sitdc M helps in managing diabetes and reduces the risk of serious complications associated with the condition. Maintaining optimal blood glucose levels can significantly decrease the chances of developing kidney damage, eye damage, nerve problems, and even the risk of limb amputation.
Furthermore, proper control of diabetes achieved through the use of Sitdc M can also lower the risk of heart disease and stroke. It is vital to take this medication regularly as prescribed, in conjunction with a balanced diet and appropriate exercise regimen. By adhering to the recommended treatment plan, you can lead a normal and healthy life while safeguarding your future health. Ignalis-M IR 50/500 Tablet plays a crucial role in not only managing diabetes but also in preventing life-threatening complications, highlighting its importance in the overall well-being of individuals with Type 2 diabetes mellitus.
How to use the Ignalis-M IR 50/500 Tablet
To make the most out of Ignalis-M IR 50/500 Tablet, it is important to follow your doctor's instructions on dosage and duration. Remember to swallow the tablet whole, without crushing, chewing, or breaking it. It is recommended to take Ignalis-M IR 50/500 Tablet with food. Follow these simple steps to ensure the medication works effectively for you.
Uses of Ignalis-M IR 50/500 Tablet
Ignalis-M IR 50/500 Tablet is primarily used for the treatment of Type 2 diabetes mellitus. This medication helps to regulate blood sugar levels in patients with this condition. It is important to follow the dosage and instructions provided by your healthcare provider to manage diabetes effectively. Ignalis-M IR 50/500 Tablet can be a beneficial part of a comprehensive treatment plan for individuals with Type 2 diabetes.
What conditions Ignalis-M IR 50/500 Tablet treats?
Ignalis-M IR 50/500 Tablet is used to treat Type 2 diabetes mellitus. It helps control high blood sugar levels to prevent complications like kidney damage, eye problems, nerve issues, and limb loss. Lowering blood sugar also reduces the risk of heart disease and stroke. Taking this medicine regularly, along with a healthy diet and exercise, is crucial for managing diabetes effectively. It is important to follow your doctor's advice and not stop medication without consulting them. Be aware of common side effects and the possibility of low blood sugar if taking other diabetes medications.
Should you consult a doctor?
It is important to seek medical advice if you experience persistent side effects while taking Ignalis-M IR 50/500 Tablet. Some common side effects include diarrhea, nausea, vomiting, upset stomach, headache, and sore throat. It is particularly important to contact your doctor if you notice signs of low blood sugar level (hypoglycemia) as this can be a serious condition, especially if you are taking other diabetes medicines like insulin or sulfonylurea. Additionally, if you have a decreased appetite, abdominal bloating, or symptoms of an upper respiratory tract infection, it is advisable to consult your healthcare provider.
Furthermore, if you have a history of kidney, liver, or heart disease, problems with your pancreas, or if you are pregnant or breastfeeding, it is essential to inform your doctor before starting Ignalis-M IR 50/500 Tablet. Your doctor will need to monitor your kidney function and blood sugar levels before and during treatment. If you experience any discomfort or concerns while taking this medication, do not hesitate to seek guidance from your healthcare provider to ensure your safety and well-being.
Side effects of Ignalis-M IR 50/500 Tablet
When taking Ignalis-M IR 50/500 Tablet, some people may experience side effects. Remember that most of these side effects are usually temporary and may go away as your body gets used to the medication. However, if you find that these side effects persist or they are concerning you, it’s important to talk to your doctor for guidance. Common side effects of Ignalis-M IR 50/500 Tablet may include decreased appetite, vomiting, upper respiratory tract infection, hypoglycemia (low blood glucose level), abdominal bloating, nausea, and diarrhea. If any of these side effects become bothersome or severe, seek medical advice promptly.
Safety advice

liver
"Ignalis-M IR 50/500 Tablet may not be safe for individuals with liver disease and should be avoided. It is important to seek advice from your doctor before using this medication."

kidney
Ignalis-M IR 50/500 Tablet requires caution in patients with kidney disease. Dose adjustment may be necessary, but it's not advised for severe kidney disease. Regular kidney function tests are recommended during treatment. Consult your doctor for proper guidance.

alcohol
Avoid consuming alcohol while taking Ignalis-M IR 50/500 Tablet. Drinking alcohol may increase the risk of side effects.

driving
If you experience low or high blood sugar, avoid driving while taking Ignalis-M IR 50/500 Tablet to prevent impaired focus and reaction time.

pregnancy
Ignalis-M IR 50/500 Tablet may be unsafe during pregnancy. Animal studies show potential harm to the developing baby. Your doctor will assess the risks and benefits before prescribing. Please consult your doctor.

breastfeeding
Ignalis-M IR 50/500 Tablet is likely unsafe during breastfeeding as it may pass into breastmilk and harm the baby. It is better to consult your doctor before using Ignalis-M IR 50/500 Tablet.
Consumption warning before consuming Ignalis-M IR 50/500 Tablet
Before consuming Ignalis-M IR 50/500 Tablet, it is essential to be aware of certain warnings. This medication is designed to manage high blood sugar levels in individuals with type 2 diabetes mellitus, aiming to prevent serious complications such as kidney damage and blindness, and lower the risk of heart-related issues. Sitdc M may be prescribed alone or in conjunction with other diabetes treatments, showing optimal results when combined with a balanced diet and regular physical activity.
To ensure effectiveness and minimize potential side effects, it is crucial to take Sitdc M consistently at the same time daily, following your doctor's instructions closely. Common side effects may include diarrhea, nausea, and headaches, while low blood sugar levels can occur when taken with other diabetes medications. In certain cases, this medicine may not be suitable, especially if you have a history of kidney, liver, or heart issues, pancreas problems, or consume alcohol regularly.
Before starting Sitdc M, inform your doctor of any underlying conditions or medications you are currently taking to avoid adverse interactions. Pregnant or breastfeeding women should consult their healthcare provider prior to use. It is also recommended to limit alcohol intake as it can impact blood sugar levels. Regular monitoring of kidney function and blood sugar levels during treatment is advised for safety.
What if you forgot to take Ignalis-M IR 50/500 Tablet?
If you forget to take a dose of Ignalis-M IR 50/500 Tablet, try to take it as soon as you remember. But if it's close to the time for your next dose, it's better to just skip the missed one and continue with your usual dosing schedule. Remember not to take a double dose to make up for the missed one. It's important to stay consistent with your medication routine to ensure effectiveness.
Related lab tests
Related Lab Tests for Ignalis-M IR 50/500 Tablet:
When taking Ignalis-M IR 50/500 Tablet, it is important to monitor certain lab tests to ensure that the medication is working effectively and to catch any potential issues early. The following lab tests are recommended for individuals on Ignalis-M IR 50/500 Tablet:
1. Glucose - Fasting Blood: This test measures the level of glucose in your blood after a period of fasting. It helps determine your baseline blood sugar levels and how well your body is processing glucose without any recent food intake.
2. Glucose - Postprandial Blood: This test measures the level of glucose in your blood after you have eaten a meal. It helps assess how your body responds to glucose intake and can provide valuable insights into your diabetes management.
3. Glycosylated Hemoglobin: Also known as HbA1c, this test measures the average blood sugar levels over the past 2-3 months. It provides a good indication of your long-term blood sugar control and how well you are managing your diabetes.
By regularly monitoring these lab tests while taking Ignalis-M IR 50/500 Tablet, you and your healthcare provider can track your blood sugar levels, assess the effectiveness of the medication, and make any necessary adjustments to your treatment plan. It is important to follow your healthcare provider's recommendations for lab testing to ensure optimal management of your diabetes while on Ignalis-M IR 50/500 Tablet.
Additional Information
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
FAQs
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹119.25
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024